OLI Technologies, Inc. — SEC Form D Filing
OLI Technologies, Inc. filed an SEC Form D on September 4, 2026, reporting $3.00M raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 4, 2026
- Amount reported
- $3.00M
- Round stage
- Seed, as a $3,000,000 equity raise is the industry standard for a life sciences startup validating its core technology and preparing for early commercialization.
- Industry
- Other Health Care
- Website
- https://www.olisystems.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Traditional oligonucleotide synthesis is slow, expensive, and struggles to reliably produce the high-purity, long-chain RNA and DNA sequences required for modern genetic therapeutics.
Solution
OLI Technologies develops an automated, high-throughput synthesis platform that accelerates the custom production of high-fidelity oligonucleotides for researchers.
Why now
The rapid clinical success of mRNA vaccines and RNA-based therapies has created unprecedented global demand for scalable, rapid, and high-purity genetic material manufacturing.
Source: SEC EDGAR Form D filing